levofloxacin has been researched along with cefazolin in 39 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (cefazolin) | Trials (cefazolin) | Recent Studies (post-2010) (cefazolin) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 3,221 | 525 | 920 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.13) | 18.2507 |
2000's | 19 (48.72) | 29.6817 |
2010's | 14 (35.90) | 24.3611 |
2020's | 4 (10.26) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
Liu, T; Lv, J; Qian, Y; Wang, Y | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Alverson, JB; Decato, D; Hoody, J; Klepacki, D; McGrath, K; Priestley, ND; Stierle, AA; Stierle, DB | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Tuohy, M; Washington, JA | 1 |
Furuya, N; Iwata, M; Matsumoto, T; Mizuiri, S; Tateda, K; Yamaguchi, K | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
Ciftçi, M; Erat, M | 1 |
Arnold, FW; Wojda, B | 1 |
Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
Aradhyula, S; Greisnauer, S; Manian, FA; Meyer, PL; Senkel, D; Setzer, J; Wiechens, M | 1 |
Kim, SY; Lee, YC; Park, YH | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Ebisutani, C; Inoue, H; Kinoshita, Y; Nishi, K; Sato, S; Yoshie, T | 1 |
Feldman, D; Sarabanchong, VO; Treszezamsky, AD | 1 |
Bian, ZQ; Han, J; Li, Y; Wang, GC; Zhang, YL; Zuo, GY | 1 |
Chen, PL; Hung, YP; Ko, WC; Wu, YH | 1 |
Ji, G; Wang, J; Wang, L; Wen, A; Wu, Y; Xi, M; Yang, Z; Yu, W; Zhao, P | 1 |
Chang, SJ; Hsieh, CH; Lin, CD; Yang, SS | 1 |
Chang, HC; Chiang, BJ; Chiang, IN; Chung, SD; Huang, CY; Liu, SP; Pu, YS; Wang, SM; Yu, HJ | 1 |
Iino, N; Koda, R; Watanabe, H | 1 |
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
Chen, J; Ed-Dra, A; Wu, B; Yue, M; Zhang, Y; Zhou, H | 1 |
Enokiya, T; Imai, H; Kato, T; Morikawa, Y; Okuda, M | 1 |
3 review(s) available for levofloxacin and cefazolin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
4 trial(s) available for levofloxacin and cefazolin
Article | Year |
---|---|
Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: an open randomized prospective study of oral versus intravenous administration.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Cefazolin; Chemoembolization, Therapeutic; Female; Humans; Inflammation Mediators; Infusions, Intra-Arterial; Infusions, Intravenous; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Ofloxacin; Postoperative Complications; Prospective Studies; Treatment Outcome | 2010 |
Prospective randomized, double-blind, placebo controlled trial to evaluate infection prevention in adult patients after tension-free inguinal hernia repair.
Topics: Adult; Aged; Antibiotic Prophylaxis; Cefazolin; Double-Blind Method; Female; Hernia, Inguinal; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Surgical Wound Infection | 2013 |
Are prophylactic antibiotics necessary in patients with preoperative sterile urine undergoing ureterorenoscopic lithotripsy?
Topics: Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Cefazolin; Ceftriaxone; Double-Blind Method; Female; Fever; Humans; Levofloxacin; Lithotripsy; Male; Middle Aged; Odds Ratio; Postoperative Complications; Practice Guidelines as Topic; Preoperative Care; Prospective Studies; Pyuria; Treatment Outcome; Ureteroscopy; Urinary Tract Infections | 2014 |
Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: an eight-year single center experience.
Topics: Antibiotic Prophylaxis; Biopsy; Cefazolin; Humans; Levofloxacin; Male; Pipemidic Acid; Prostate; Retrospective Studies; Taiwan; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections | 2013 |
32 other study(ies) available for levofloxacin and cefazolin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cations; Drug Evaluation, Preclinical; Methicillin Resistance; Microbial Sensitivity Tests; Quinine; Staphylococcus aureus | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The Berkeleylactones, Antibiotic Macrolides from Fungal Coculture.
Topics: Anti-Bacterial Agents; Coculture Techniques; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Penicillium; Streptococcus pneumoniae; Streptococcus pyogenes | 2017 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
Primary Shewanella alga septicemia in a patient on hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Renal Dialysis | 1999 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Topics: Animals; Blood Vessel Prosthesis Implantation; Cefazolin; Drug Evaluation, Preclinical; Drug Implants; Drug Resistance; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Methicillin Resistance; Models, Animal; Ofloxacin; Oxacillin; Premedication; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin | 2001 |
In vitro effects of some antibiotics on glutathione reductase from sheep liver.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cefepime; Cephalosporins; Gentamicins; Glutathione Reductase; In Vitro Techniques; Levofloxacin; Liver; Ofloxacin; Sheep; Thiamphenicol | 2003 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea.
Topics: Aged; Analysis of Variance; Case-Control Studies; Cefazolin; Ceftriaxone; Clostridioides difficile; Confidence Intervals; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Levofloxacin; Male; Missouri; Multivariate Analysis; Odds Ratio; Ofloxacin; Regression Analysis; Retrospective Studies; Risk Factors | 2007 |
Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aza Compounds; Cefazolin; Cell Count; Cornea; Endothelium, Corneal; Fluoroquinolones; Injections; Levofloxacin; Microscopy, Electron, Scanning; Moxifloxacin; Ofloxacin; Quinolines; Rabbits | 2008 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean Section; Chorioamnionitis; Female; Humans; Levofloxacin; Metronidazole; Ofloxacin; Postoperative Complications; Postpartum Period; Pregnancy; Streptococcal Infections; Streptococcus anginosus; Surgical Wound Dehiscence; Uterus; Vasculitis | 2011 |
Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Berberine; Cefazolin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Synergism; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin | 2012 |
Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Risk Factors; Taiwan; Urinary Tract Infections; Young Adult | 2014 |
Mycotic Aneurysm of the Abdominal Aorta Complicated With Iliopsoas Abscess and Infectious Spondylodiscitis in a Long-Term Hemodialyzed Patient: A Rare but Serious Complication of Staphylococcus Aureus Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteremia; Cefazolin; Ceftriaxone; Discitis; Drainage; Humans; Levofloxacin; Male; Middle Aged; Psoas Abscess; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Antimicrobial resistance and genomic investigation of non-typhoidal
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefazolin; Doxycycline; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Outpatients; Salmonella; Salmonella Infections; Streptomycin; Tetracycline | 2022 |
Sequestration of Antimicrobial Agents in Xcoating and Heparin-Coated Extracorporeal Membrane Oxygenation Circuits: An In Vitro Study.
Topics: Animals; Anti-Infective Agents; Cattle; Cefazolin; Daptomycin; Doripenem; Extracorporeal Membrane Oxygenation; Heparin; Humans; Levofloxacin | 2023 |